Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.44 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HCAR1 | Q9BXC0 | 2/20 | 0.40 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27377612 | 0.87 | FEN1 (0.57) | FEN1MEN1KMT2ALMNAGRM4 | |
| SCHEMBL29326231 | 0.84 | ITGA4 (0.44) | FEN1TDP1ITGA4ITGB7KDM4E | |
| SCHEMBL29326616 | 0.77 | IDO1 (0.44) | FEN1TDP1ITGA4ITGB7KDM4E | |
| SCHEMBL29326223 | 0.76 | FEN1 (0.58) | FEN1TDP1KDM4ELMNAALDH1A1 | |
| SCHEMBL29959950 | 0.76 | FEN1 (1.00) | FEN1KDM4EALDH1A1ADORA2AADORA2B | |
| SCHEMBL18687486 | 0.76 | FEN1 (1.00) | FEN1KDM4EALDH1A1ADORA2AADORA2B | |
| SCHEMBL6976268 | 0.74 | NPEPPS (0.63) | FEN1TDP1KDM4EALDH1A1HTT | |
| SCHEMBL27377613 | 0.74 | FEN1 (0.40) | FEN1ITGA4ITGB7KDM4EMEN1 | |
| SCHEMBL29326603 | 0.71 | KDM4E (0.40) | TDP1ITGA4ITGB7KDM4EMEN1 | |
| SCHEMBL29326224 | 0.70 | NPEPPS (0.48) | FEN1TDP1ITGA4ITGB7KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | ACE2, TMPRSS2, ACE | FEN1 1012/4885TDP1 2732/4885ITGA4 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.